Episode 1: Venrock's Bryan Roberts
BioVenture VoiCes with Chris Garabedian
00:00
Views on AI/ML in drug discovery
Bryan explains Venrock hasn't invested in ML-only discovery but uses these tools; he sees near-term promise in antibody design.
Play episode from 37:40
Transcript
